NewsRx

Search our medical news database

Occupational Risk

Protocol for Follow-up After HCV Exposure Needed

Published in Medical Letter on the CDC and FDA, August 18th, 1997

A protocol for the follow-up of healthcare workers exposed to hepatitis C virus is desperately needed, but limited data on occupational risk, transmission risk, and the benefits of therapy are hampering efforts to fashion one, according to a report from the U.S. Centers for Disease Control and Prevention (CDC).

"In the absence of 1) pre-exposure or post-exposure prophylaxis, 2) recommendations that are unique for hepatitis C virus (HCV) to prevent HCV transmission to others, and 3) effective therapy for most persons with chronic hepatitis C, the overall public health benefit associated with the identification of HCV infections in healthcare workers will be limited," the...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook